M. Hosokawa et al., INTERINDIVIDUAL VARIATION IN CARBOXYLESTERASE LEVELS IN HUMAN LIVER-MICROSOMES, Drug metabolism and disposition, 23(10), 1995, pp. 1022-1027
Microsomal carboxylesterase activities in 12 human livers were determi
ned using 10 kinds of carboxylesterase substrates (p-nitrophenylacetat
e, p-nitrophenylpropionate, p-nitrophenylbutyrate, butanilicaine, isoc
arboxazid, palmitoyl-coenzyme-A, malathion, clofibrate, acetanilide, a
nd phenacetin), There were large individual differences in the 12 huma
ns based on experimental results in the past several years in our labo
ratory, We found that all human liver microsomes have RH1-immunoreacti
ve carboxylesterase, and the carboxylesterase content in liver also sh
owed large individual differences, The RH1-immunoreactive carboxyleste
rase concentration correlated well with those of p-nitrophenylesters,
clofibrate, butanilicaine, and isocarboxazid, and anti-RH1 immunoglobu
lin G strongly inhibited human liver hydrolase activity. These finding
s indicate that one major carboxylesterase isozyme that is immunoreact
ive with anti-RH1 in human liver microsomes has catalytic activity on
major carboxylesterase substrates, and thus hydrolase activity in huma
n liver depends on the expression level of this carboxylesterase isozy
me. These observations should be useful in understanding the action of
carboxylesterases on drug metabolism in humans.